Pooled analysis of the surgical treatment for colorectal cancer liver metastases

Critical Reviews in Oncology/Hematology

Volumn 94, Issue 1, 2015, Pages 122-135

  Veereman, G ^a   Robays, J ^a   Verleye, L ^a   Leroy, R ^a   Rolfo, C ^b   Van Cutsem, E ^c   Bielen, D ^c   Ceelen, W ^d   Danse, E ^e   De Man, M ^f   Demetter, P ^g   Flamen, P ^h   Hendlisz, A ^h   Sinapi, I ⁱ   Vanbeckevoort, D ^c   Ysebaert, D ^b   Peeters, M ^b  

^a BELGIAN HEALTH CARE KNOWLEDGE CENTRE KCE   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

^e Catholic University Leuven   (Belgium)

^f OLV HOSPITAL   (Belgium)

^g UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^h JULES BORDET INSTITUTE   (Belgium)

ⁱ Grand HÔpital de Charleroi ^*  (Belgium)

Author keywords

Colorectal cancer; Hepatic metastasis; Liver metastasis; Metachronous metastasis; Synchronous metastasis

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; COLORECTAL CANCER; COLORECTAL LIVER METASTASIS; COLORECTAL SURGERY; DIARRHEA; DRUG FATALITY; EVIDENCE BASED MEDICINE; HEPATIC ARTERY; HUMAN; LEUKOPENIA; LIVER RESECTION; LIVER SURGERY; LIVER TOXICITY; META ANALYSIS (TOPIC); MORBIDITY; NAUSEA; NEUTROPENIA; OBSERVATIONAL STUDY; OPERATION DURATION; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; REVIEW; SURVIVAL RATE; SYSTEMATIC REVIEW; TIME TO TREATMENT; TREATMENT PLANNING; VOMITING; CANCER GRADING; CANCER STAGING; COLORECTAL NEOPLASMS; LIVER NEOPLASMS; META ANALYSIS; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROCEDURES; SECONDARY; TIME; TREATMENT OUTCOME;

COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; LIVER NEOPLASMS; NEOPLASM GRADING; NEOPLASM STAGING; TIME FACTORS; TREATMENT OUTCOME;

EID: 84926105447     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2014.12.004     Document Type: Review

References (30)

1. Group USCSW United States Cancer Statistics: 1999-2010 incidence and mortality web-based report 2013, Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute, Atlanta (GA).
2. Belgian Cancer Registry Cancer survival in Belgium 2012.
3. Goyer P., Karoui M., Vigano L., et al. Single-center multidisciplinary management of patients with colorectal cancer and resectable synchronous liver metastases improves outcomes. Clin Res Hepatol Gastroenterol 2013, 37(February):47-55.
4. Gallinger S., Biagi J.J., Fletcher G.G., et al. The role of liver resection in colorectal cancer metastases. Program in evidence-based care evidence-based series 2012, 6-7. C.C. Ontario (Ed.).
5. NICE Clinical Guideline Colorectal cancer: the diagnosis and management of colorectal cancer 2011.
6. SIGN SIGN 126: diagnosis and management of colorectal cancer 2011.
7. Kanas G.P., Taylor A., Primrose J.N., et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol 2012, 4:283-301.
8. IKNL Colorectale levermetastasen 2006.
9. van Lienden K.P., van den Esschert J.W., de Graaf W., et al. Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol 2013, 36(1):25-34.
10. Zalinski S., Mariette C., Farges O., et al. Management of patients with synchronous liver metastases of colorectal cancer. Clinical practice guidelines. Guidelines of the French society of gastrointestinal surgery (SFCD) and of the association of hepatobiliary surgery and liver transplantation (ACHBT). Short version. J Visc Surg 2011, 148:e171-e182.
11. Tonelli F., Leo F., Nobili S., et al. Prognostic factors in primary and iterative surgery of colorectal liver metastases. J Chemother 2010, 22:358-363.
12. IKNL Coloncarcinoom Landelijke richtlijn met regionale toevoegingen 2008.
13. Wieser M., Sauerland S., Arnold D., et al. Peri-operative chemotherapy for the treatment of resectable liver metastases from colorectal cancer: a systematic review and meta-analysis of randomized trials. BMC Cancer 2010, 10.
14. Ciliberto D., Prati U., Roveda L., et al. Role of systemic chemotherapy in the management of resected or resectable colorectal liver metastases: a systematic review and meta-analysis of randomized controlled trials. Oncol Rep 2012, 27:1849-1856.
15. Nelson R.L., Freels S. Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver. Cochrane Database Syst Rev 2009.
16. Chua T.C., Saxena A., Liauw W., et al. Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases. Ann Surg Oncol 2010, 17:492-501.
17. Lehmann K., Rickenbacher A., Weber A., et al. Chemotherapy before liver resection of colorectal metastases: friend or foe. Ann Surg 2012, 255:237-247.
18. Quan D., Gallinger S., Nhan C., et al. The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: a systematic review. Surgery (United States) 2012, 151:860-870.
19. Chen M.L., Fang C.H., Liang L.S., et al. A meta-analysis of chemotherapy regimen fluorouracil/leucovorin/oxaliplatin compared with fluorouracil/leucovorin in treating advanced colorectal cancer (structured abstract). Surg Oncol 2010, 19:38-45.
20. Nordlinger B., Sorbye H., Glimelius B., et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC intergroup trial 40983): a randomised controlled trial. Lancet 2008, 371:1007-1016.
21. Nordlinger B., Sorbye H., Glimelius B., et al. EORTC liver metastases intergroup randomized phase III study 40983: long-term survival results. J Clin Oncol 2012, 30. abstr 3508.
22. Nordlinger B., Sorbye H., Fau-Glimelius B., et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol 2013, 14:1208-1215. doi:1210.1016/S1470-2045(1213)70447-70449. Epub 72013 Oct 70411.
23. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
24. Parmar M.K., Torri V., Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998, 17:2815-2834.
25. Julina P.T., Higgins S.G. Cochrane Handbook for Systematic Reviews of Interventions 2008, 361-366. Wiley-Blackwell.
26. Balshem H., Helfand M., Schunemann H.J., et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011, 64:401-406.
27. Chen J., Li Q., Wang C., et al. Simultaneous vs. staged resection for synchronous colorectal liver metastases: a metaanalysis. Int J Colorectal Dis 2011, 26:191-199.
28. Yin Z., Liu C., Chen Y., et al. Timing of hepatectomy in resectable synchronous colorectal liver metastases (SCRLM): simultaneous or delayed. Hepatology 2013, 57:2346-2357.
29. De Rosa A., Gomez D., Brooks A., Cameron I.C. Liver-first approach for synchronous colorectal liver metastases: is this a justifiable approach. J Hepatobiliary Pancreat Sci 2013, 20:263-270.
30. Peeters M., Leroy R., Robays J., et al. Colon cancer: diagnosis, treatment and follow-up. KCE reports 2014, 112. Belgian Health Care Knowledge Centre (KCE), Brussels.